Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine

Thumbnail Image

Files

Short- and Long-term Humoral Response ofImmunosuppressed_2025.pdf (386.97 KB)
Identifiers
URI: https://hdl.handle.net/11268/16626
DOI: 10.1097/INF.0000000000005042

Publication date

2025

Authors

Gastesi, Irati
Hotterbeekx, An
Aguilera Alonso, David
Konnova, Angelina

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

SDG

goal-3

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

This study aimed to evaluate in detail the short- and long-term humoral responses to the BNT162b2 (BioNTech, SE, Mainz, Germany/Pfizer Inc, New York, NY) vaccine in immunosuppressed children aged 5–11 years compared with healthy children.

Description

UNESCO Subjects

Pandemia
Pediatría
Inmunología

Keywords

Bibliographic reference

Tagarro, A., Gastesi, I., Hotterbeekx, A., Aguilera-Alonso, D., Konnova, A., Gupta, A., Salso, S., Berkell, M., Plata, M. D. C., Domínguez-Rodríguez, S., Ballesteros, Á., Manzanares, Á., Oltra, M., Villanueva, S., Pinto, C., Guillén, R., Giaquinto, C., Moraleda, C., & Kumar-Singh, S. (2025). Short- and long-term humoral response of immunosuppressed children to sars-cov-2 bnt162b2 vaccine. Pediatric Infectious Disease Journal. https://doi.org/10.1097/INF.0000000000005042
Editor's version
http://doi.org/10.1097/INF.0000000000005042

Type of document

journal article

Collections

Área de Ciencias de la Salud